Julien De Greef - Infectious Diseases

Author Information

Julien De Greef is affiliated with the Department of Internal Medicine and Infectious Diseases at the Cliniques universitaires Saint Luc in Brussels, Belgium. His work primarily focuses on the intersection of infectious diseases and internal medicine, with an emphasis on studies related to COVID-19, particularly in vulnerable populations such as kidney transplant recipients and dialysis patients.

Research Contributions

Julien De Greef has made significant contributions to the field of infectious diseases through a variety of research studies. In 2022, his work included a randomized controlled trial on improving oxygen delivery systems for COVID-19 patients and studies on the management of infections in kidney transplant recipients, including monoclonal antibody therapy and immunosuppression impacts. His earlier work in 2021 included investigations into vaccine responses in dialysis patients and kidney transplant recipients, as well as the benefits of telerehabilitation for COVID-19 patients. These studies reflect his commitment to advancing treatment and management strategies for infectious diseases in compromised patient groups.

Aliases

Julien De Greef is also known by several variations of his name, including J De Greef and J. De Greef. These aliases are likely used in different publications and databases, reflecting minor variations in name formatting.

Publication and Citation Metrics

Metric Value
Total Citation Count 991
H-Index 14
Total Paper Count 57

Publications:

DOI: 10.4187/respcare.09312

Year: 2022

Partnered Content Networks

Relevant Topics